If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
This medicinal product has been authorised under a so-called ‘conditional approval’ scheme. This means that further evidence on this medicinal product is awaited. The Agency will review new information on this medicinal product at least every year and the Summary of Product Characteristics will be updated as necessary.
PAXLOVID ▼ (nirmatrelvir/ritonavir)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Paxlovid Quick Finders
Chat online with Pfizer Medical Information regarding your enquiry on Paxlovid. Please select Paxlovid on the first menu.
Submit your medical enquiry on a Pfizer medicine
*Speak live with a Pfizer Medical Information professional regarding your medical enquiry from Monday to Friday between 09:00 AM and 17:00 PM (excluding holidays).
In the event of a suspected adverse event or side effect with no associated medical information enquiry, please contact [email protected] Please always specify your country (i.e. England, Scotland, Wales or Northern Ireland). If you have a medical information enquiry including those with associated adverse events, contact Medical Information at the contacts above/ at the contacts available in this page.
Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.